Betterchem
Health     Industry Portals     News     For Consumers     21CFR     Search     Site Map

 
IRBESARTAN

 
 

Access the updated page using the API Locator.

 

Our Custom Search for Pharma News…

 
 
 
 
 
 
 
 

 


 

FDA Approval Activities for this Drug…

Avalide (irbesartan/hydrochlorothiazide) Tablets,72/12.5, 150/12.5, & 300/12.5 mg, Bristol-Myers Squibb NDA 20-758/S16 | Avapro (irbesartan) Tablets, 75, 150, & 300 mg, Sanofi-Synthelabo, NDA 20-757/S22 7/19/02 7/24/02 | Avapro (irbesartan) Tablets, 75, 150, & 300 mg, Sanofi-Synthelabo, NDA 20-757/S21 9/17/02 9/20/02 9/17/02 11/22/02 | Avapro (irbesartan) Tablets, 75, 150, & 300 mg, Bristol-Myers Squibb NDA 20-757/S16 5/10/00 6/6/01 | Avapro (irbesartan) Tablets, 75, 150, & 300 mg, Bristol-Myers Squibb NDA 20-757/S15 5/9/00 6/6/01 | Avapro (irbesartan) Tablets, Bristol-Myers Squibb NDA 20-757/S14 5/26/01 12/4/01 | Avapro HCT Tablets, 75/12.5 & 150/12.5 Bristol-Myers Squibb NDA 20-758/S-003 8/31/98 3/10/00 | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Synthelabo, Formulation Revision | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling Revision | Avapro (irbesartan) Tablets, Bristol-Myers Squibb, Labeling Revision | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Avalide (irbesartan-hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling Revision | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Irbesartan Tabelts, Teva Pharma, Tentative Approval | Irbesartan Tablets, Sandoz Inc., Tentative Approval | Irbesartan and Hydrochlorothiazide Tablets, Sandoz Inc., Tentative Approval | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Aventis, New or Modified Indication | Irbesartan and Hydrochlorothiazide Tablets, Mylan Pharmaceuticals, Inc., Tentative Approval | Irbesartan Tablets, Cipla Ltd., Tentative Approval | Avalide (irbesartan and hydrochlorothiazide) Tablets, Bristol-Myers Squibb Company, Labeling Revision | Irbesartan Tablets, Alembic Limited, Tentative Approval | Irbesartan Tablets, Zydus Pharmaceuticals USA Inc., Tentative Approval | Irbesartan and Hydrochlorothiazide Tablets, Zydus Pharmaceuticals USA Inc., Tentative Approval | Irbesartan and Hydrochlorothiazide Tablets, Roxane Laboratories, Inc., Tentative Approval | Avalide (hydrochlorothiazide and irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Irbesartan Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Irbesartan Tablets, Lupin Limited, Tentative Approval | Irbesartan Tablets, MacLeods Pharmaceuticals Ltd., Tentative Approval | Irbesartan and Hydrochlorothiazide Tablets, MacLeods Pharmaceuticals Ltd., Tentative Approval | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision

View updates.

                                                                   

 

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP

© 2012 Betterchem.com